Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Congenital Muscular Dystrophy Advanced Sequencing Evaluation Athena Diagnostics United States | 37 | 23 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
Bioarray Spain | 1 | 1 |
|
Congenital muscular dystrophy due to laminin alpha2 deficiency Bioarray Spain | 1 | 1 |
|
CeGaT GmbH Germany | 1 | 1 |
|
CeGaT GmbH Germany | 37 | 32 |
|
Muscle Disease with CNS Involvement MGZ Medical Genetics Center Germany | 3 | 26 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 259 | 112 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
Fulgent Genetics United States | 186 | 106 |
|
Muscular Dystrophies NGS Panel Fulgent Genetics United States | 125 | 42 |
|
LAMA2-Related Muscular Dystrophy MGZ Medical Genetics Center Germany | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.